Back to search

Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.

Data up to Jan 2025

Published2003
Citations153
References24

Total Citations Per Year

Abstract

References (24)

Stat3 as an Oncogene

1999 • 2,770 citations

NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer

2000 • 2,394 citations

STATs in oncogenesis

2000 • 1,723 citations

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

2001 • 751 citations

Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers.

1998 • 570 citations

Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.

2001 • 413 citations

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

2000 • 409 citations

STAT signaling in head and neck cancer

2000 • 374 citations

Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.

2001 • 318 citations

Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)-epigallocatechin gallate in human A431 epidermoid carcinoma cells

1997 • 293 citations

Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.

1999 • 293 citations

The Anthocyanidins Cyanidin and Delphinidin Are Potent Inhibitors of the Epidermal Growth-Factor Receptor

2001 • 255 citations

Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction

2002 • 240 citations

Roles of JAKs in Activation of STATs and Stimulation of c-fos Gene Expression by Epidermal Growth Factor

1996 • 221 citations

Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells.

2002 • 209 citations

Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation.

2002 • 205 citations

STAT3 mediates the survival signal in oncogenicras-transfected intestinal epithelial cells

1998 • 130 citations

ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells

1999 • 122 citations

Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A

1997 • 96 citations

Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastoma

2000 • 89 citations

Developments in chemotherapy of breast cancer

2000 • 81 citations

Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy.

2001 • 77 citations

Taxanes in combined modality therapy for solid tumors

2001 • 77 citations

The Roles of JNK1 and Stat3 in the Response of Head and Neck Cancer Cell Lines to Combined Treatment with All trans‐retinoic Acid and 5‐Fluorouracil

2002 • 40 citations

Cited By (0)

No citing papers found in database

Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling… (2003) – PubMed | Metascience Observatory Explorer